BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/10/2014

FDA Clears DIAMOX (Acetazolamide) for Continued Approval

The FDA has determined that DIAMOX (acetazolamide) intravenous and tablets were not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.

Source: Federal Register — Food and Drug AdministrationOpen original release →